Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves ...

SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

Merck (MRK) announced on Wednesday that its single-tablet antiviral regimen, doravirine and islatravir for adults with HIV, ...

Researchers have found in the phase II SOLSTICE trial that the investigational combination of tobevibart plus elebsiran ...

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. HBV is a major cause of HCC. There are no standard adjuvant treatments to ...

Among adults hospitalized with influenza-associated pneumonia, delayed vs timely antiviral treatment initiation was associated with greater 30-day mortality risk. Delayed antiviral therapy initiation ...

Please provide your email address to receive an email when new articles are posted on . Only about one in four patients with hepatitis C virus-related hepatocellular carcinoma receive direct-acting ...

Please provide your email address to receive an email when new articles are posted on . Adjusted analysis demonstrated no association between nucleos(t)ide analogue retreatment and HBsAg seroclearance ...

This retrospective cohort study used data from the Veterans Health Administration to assess the association between chronic untreated HCV and incident PDAC and whether different HCV genotypes affect ...